Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

9 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Glasgow Coma Scale (EHR Archetype) - openEHR-EHR-OBSERVATION.glasgow_coma_scale.v1

- 09/07/2017 - 1 Formulaire, 1 Groupe Item, 7 Eléments de données, 4 Langues
Groupe Item: openEHR-EHR-OBSERVATION.glasgow_coma_scale.v1.xml
Derived from www.openehr.org . Use to record clinical responses of an adult subject of care to stimuli. It is commonly used to establish a baseline conscious state and neurological function assessment and/or to detect patients who may require immediate medical intervention. The Glasgow coma scale has three subscales E (eye), V (verbal) and M (motor). In clinical practice all three subscales are reported individually plus the 'Total score', if applicable. A recorded response for each of E, V and M is mandatory. If a response cannot be tested, then the 'Not Applicable' null flavour should be recorded; do not use the 'None' ordinal value to record a missing component. Details about the reason for not being able to test a response can be recorded in the 'Confounding factors' data element. The 'Total score' can be derived as the sum of the recorded eye, motor and verbal response scores. It is not appropriate to report a 'Total score' when one or more components are not testable because the score will be artificially low - in this situation record the EVM profile instead. The three response values are considered separately as well as their sum. The 'EVM profile' can be derived as a concatenation of each of the recorded eye, motor and verbal response scores. For example, E3 V4 M2 represents the conscious state of a subject who opens eyes to speech, utters incomprehensible sounds and has an extensor response to stimulation. The minimum possible 'Total score' value is 3 (equivalent to E1 V1 M1) and the maximum possible is 15 (equivalent to E4 V5 M6). In practical use, Glasgow coma scale is recorded as one component of clinical monitoring, using sequential and repeated point-in-time measurements. Date and time should be recorded for each measurement, as well as any factors that may influence interpretation of changes. Changes in 'Total score' or any E, V or M values may have as much clinical significance as the value recorded initially.

Pediatric surgery UKM - Head injury admission form

- 27/09/2021 - 1 Formulaire, 3 Groupes Item, 22 Eléments de données, 2 Langues
Groupes Item: Patient identification, Glasgow coma scale, Neurological assessment
Head injury admission form converted to ODM format. Routine documentation of University Hospital of Münster.

SB-681323 in ALI/ARDS risk patients - NCT00996840 - Trauma

- 20/07/2019 - 1 Formulaire, 4 Groupes Item, 6 Eléments de données, 1 Langue
Groupes Item: Administrative Data, Trauma, Glasgow Coma Scale, Injury Severity Score
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains data on the participant's initial trauma, and is to be filled in at Screening.

Score Time interval 24 hours before randomization CandiSep Anesthesiology and Intensive Care NCT02734550 - Score

- 03/07/2018 - 1 Formulaire, 2 Groupes Item, 2 Eléments de données, 1 Langue
Groupes Item: Glasgow-Coma-Scale, Charlson- Comorbidity Index
Study part: Glasgow-Coma-Scale and Charlson- Comorbidity Index. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Glasgow Coma Scale Routine documentation in German hospitals DMI

- 02/08/2017 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 2 Langues
Groupes Item: health condition, Glasgow Coma Scale
Routine documentation in German hospitals. Source file name: VL010106_Glasgow_Coma_Scale Examplary forms provided by DMI (http://www.dmi.de/)

Glasgow Coma Scale Routine documentation in German hospitals DMI

- 31/07/2017 - 1 Formulaire, 1 Groupe Item, 8 Eléments de données, 2 Langues
Groupe Item: Glasgow Coma Scale
Routine documentation in German hospitals. Source file name: VL010106_Glasgow_Coma_Scale Examplary forms provided by DMI (http://www.dmi.de/)

Glasgow Coma Scale, pediatric Routine documentation in German hospitals DMI

- 30/07/2017 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 2 Langues
Groupes Item: Glasgow Coma Scale pediatric, grading PGCS
Routine documentation in German hospitals. Source file name: VL010106_Glasgow_Coma_Scale Examplary forms provided by DMI (http://www.dmi.de/)

Emergency Room Point B in Time Part 1: Emergency Room Report UKM

- 03/07/2016 - 1 Formulaire, 15 Groupes Item, 119 Eléments de données, 2 Langues
Groupes Item: Patient information, Emergency Room Team, Medical history, Vital signs, Surgical interventions until admission in ICU, Diagnostics until admission in ICU, Neurological examination, Blood test, Clinical course, ASA, Therapy, Hemostasis Therapy, Further treatment, Urinary diversion, PTS
Report/Protocol collecting patient and treatment information like the circumstances of the accident and initial ER treatment. http://klinikum.uni-muenster.de/

Outcome Prognosis Thromboembolic Events Point D1 in Time DGU TraumaRegister questionnaire

- 27/05/2016 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 2 Langues
Groupes Item: General Information, For Germany only
2 3 4 5 DGU TraumaRegister® questionnaire; Data are collected prospectively in four consecutive time phases from the site of the accident until discharge from hospital: A) Pre-hospital phase, B) Emergency room and initial surgery, C) Intensive care unit and D) Discharge. The documentation includes detailed information on demographics, injury pattern, comorbidities, pre- and in-hospital management, course on intensive care unit, relevant laboratory findings including data on transfusion and outcome of each individual. The inclusion criterion is admission to hospital via emergency room with subsequent ICU/ICM care or reach the hospital with vital signs and die before admission to ICU. The infrastructure for documentation, data management, and data analysis is provided by AUC - Academy for Trauma Surgery (AUC - Akademie der Unfallchirurgie GmbH), a company affiliated to the German Trauma Society. The scientific leadership is provided by the Committee on Emergency Medicine, Intensive Care and Trauma Management (Sektion NIS) of the German Trauma Society. The participating hospitals submit their data anon-ymously into a central database via a web-based application. Scientific data analysis is approved according to a peer review procedure established by Sektion NIS. TraumaRegister DGU® - Hinweise für die Publikation von Ergebnissen 5 März 2014 Seite 3 von 3 © 2014 TraumaRegister DGU® / AUC GmbH The participating hospitals are primarily located in Germany (90%), but a rising number of hospitals of other countries contribute data as well (at the moment from Austria, Belgium, China, Finland, Luxembourg, Slovenia, Switzerland, The Netherlands, and the United Arab Emirates). Currently, approx. 25,000 cases from more than 600 hospitals are entered into the database per year. Participation in TraumaRegister DGU® is voluntary. For hospitals associated with TraumaNetzwerk DGU®, however, the entry of at least a basic data set is obligatory for reasons of quality assurance. www.traumaregister-dgu.de

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial